by spacedoc » Thu Oct 13, 2005 1:43 pm
It has been brought to my attention that Pfizer is planning a new combination of Lipitor and Zetia, in essence copying the recent marketing strategy of a sister drug company combining Zetia with Zocor, thereby yielding Vytorin. Readers might be interested to learn that over the past six months Vytorin has achieved the dubious distinction of causing the majority of patient adverse reports. Fully 60% of the side effect letters I now receive are associatd with Vytorin use. The side effects range from cognitive and affective to muscle aches and pains to neuropathies. In my judgment, when Pfizer does this, it will be a huge step backwards for the public.